Facebook
X
LinkedIn
ForwardMCI Multispecialty Grand Rounds –Updates in Management of Early-Stage Non-Small Cell Lung Cancer
Join us for an engaging lecture highlighting the latest breakthroughs in clinical trials for stage I–III non-small cell lung cancer. We’ll explore cutting-edge data from neoadjuvant, peri-operative, and adjuvant studies,
while tackling some of the most pressing clinical controversies— including when to prioritize a neoadjuvant approach versus surgery first, and how to best integrate immunotherapy after surgery for patients who
have already received neoadjuvant treatment. This session will also spotlight ongoing trials and future directions, offering a forward-looking perspective on how evolving strategies may reshape the standard of care.
Target Audience
Oncologists, Radiation Oncologists, Hematology Oncologists, Radiation Therapists, Endocrinologists, Pulmonologists, Otolaryngologists, Urologists, Colo -rectal Surgeons, Neurologists, General Surgeons, General Practitioners, Obstetricians and Gynecologists, Nurses, Pharmacists, Patient Navigators and all other interested healthcare professionals.
Learning Objectives
- Demonstrate the ability to identify appropriate candidates for neoadjuvant chemotherapy and immunotherapy followed by surgical resection in non-small cell lung cancer (NSCLC).
- Accurately differentiate clinical trial designs, endpoints, and reported outcomes across neoadjuvant, peri-operative, and adjuvant immunotherapy studies in NSCLC.
- Apply evidence-based criteria to recognize patients who are not suitable candidates for immunotherapy in early-stage NSCLC.
Ryan Gentzler, M.D.
Medical Oncology
University of Virginia
School of Medicine
Charlottesville, VA
Ryan Gentzler, M.D., faculty for this educational activity has received grant/research support from Pfizer, Arrivent, Eli Lily, Prelude Therapeutics, Tempus, Nalo. Puma, Mirati, BMS, Dizal, Chugai, Amgen, AstraZeneca and Merck. He is a consultant for Boehringer Ingelheim, AstraZeneca, GSK, Abbvie, Daiichi Sankyo, Amgen, Genentech, Regeneron, Merus Takeda and Gilead. He has indicated that the presentation and discussion will not include off-label or unapproved product usage.
Firas El Chaer, M.D., conference director of this educational activity, is a consultant for Morphosys and an advisor for Amgen, PharmaEssentia, Geron, Syndax, Abbvie, AMPO and CTI Biopharma.
Robert Press, M.D., conference director of this educational activity, does not have any financial relationships with ineligible companies to disclose.
All relevant financial relationships listed for these individuals have been mitigated.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.
*Ineligible Companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 1 credit hour, CE Broker Course #20-680158, by the Florida Boards of Medicine, Osteopathic Medicine and by the Florida Council of Physician Assistants.
This activity has also been approved for 1 credit hour for Nurse Practitioners, Nurses, Pharmacists and Techs, Dietitians, and Respiratory Therapists. Baptist Health South Florida CE Broker Provider #50-182.
American Board of Surgery - Maintenance of Certification (MOC) - Accredited CME- Complex General Surgery Oncology
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.
Your participation information will be shared with specialty boards through the ACCME's PARS reporting system. Submissions are recorded in approximately 48 hours. You will receive an email when your credits have been processed.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Florida Board of Dietitians
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Pharmacy
- 1.00 Florida Board of Respiratory Therapy
Required Hardware/Software
Preregistration Required
Preregistration is required to receive the login information.
- Please register for the CME webinar to receive confirmation of your registration.
- After your registration is confirmed you will receive an email directly from Zoom, our webinar host. Please add [email protected] to your address book to ensure delivery.
Continuing Education Credits
In order to confirm your participation in a live webinar and claim credit, please:
- Provide your full name and email address when you register for the webinar.
- Complete the post-conference evaluation and attestation form, which will be emailed to you after the activity.
Required Hardware/Software
 | Supported DevicesWhile the presentations may be viewable on systems that don't meet these criteria, it is recommended that your computer meet the minimum system requirements. Visit the Zoom Rooms page for system requirements and recommendations. Please plan to connect to the webinar transmission 15 minutes prior to the start time to test your connectivity. |
 | Technical SupportYou can test your connection to Zoom prior to the scheduled time by visiting Zoom Help Center. If you have technical difficulties accessing a webinar, please first consult our Zoom Rooms and troubleshooting tips. If your system meets these parameters, for technical assistance, call 888-799-9666. |